Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ampio Pharmaceuticals, Inc. (AMPE)
:AMPE
Holding AMPE?
Track your performance easily
AMPE Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $2.47
Previous CloseN/A
Volume38.00
Average Volume (3M)1.39K
Market Cap
$2.95K
Enterprise ValueN/A
Total Cash (Recent Filing)$5.02M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-35.39
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Jan 05, 2016Dividend YieldN/A
Share Statistics
EPS (TTM)-11.09
Shares Outstanding1,135,358
10 Day Avg. Volume56
30 Day Avg. Volume1,388
Standard Deviation2.74
R-Squared0.00497
Alpha0.23
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ampio Pharmaceuticals News
PremiumCompany Announcements
Ampio Pharmaceuticals Ends Equity Distribution and Alters Strategy
PremiumCompany Announcements
Ampio Pharmaceuticals Announces Nonclinical Study Success
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
AMPE FAQ
What was Ampio Pharmaceuticals, Inc.’s price range in the past 12 months?
Ampio Pharmaceuticals, Inc. lowest stock price was <$0.01 and its highest was $2.47 in the past 12 months.
What is Ampio Pharmaceuticals, Inc.’s market cap?
Ampio Pharmaceuticals, Inc.’s market cap is $2.95K.
When is Ampio Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ampio Pharmaceuticals, Inc.’s earnings last quarter?
Ampio Pharmaceuticals, Inc. released its earnings results on May 11, 2023. The company reported -$0.264 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.264.
Is Ampio Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts Ampio Pharmaceuticals, Inc.’s price is currently Overvalued.
Does Ampio Pharmaceuticals, Inc. pay dividends?
Ampio Pharmaceuticals, Inc. pays a Notavailable dividend of $209.7 which represents an annual dividend yield of N/A. See more information on Ampio Pharmaceuticals, Inc. dividends here
What is Ampio Pharmaceuticals, Inc.’s EPS estimate?
Ampio Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ampio Pharmaceuticals, Inc. have?
Ampio Pharmaceuticals, Inc. has 1,135,358 shares outstanding.
What happened to Ampio Pharmaceuticals, Inc.’s price movement after its last earnings report?
Ampio Pharmaceuticals, Inc. reported an EPS of -$0.264 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Ampio Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in AMPE
---
Company Description
Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.
---
Technical Analysis
Citius Pharmaceuticals
―
Cyclacel Pharmaceuticals
―
Trevena
―
Atossa Therapeutics
―
Soligenix
―
Eagle Pharmaceuticals
―
---